Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "microRNA 6766" (miR-6766, MIR6766, hsa-mir-6766) appears to be incorrect or not well-supported by credible scientific sources. Although there are extensive data about miR-766 and various other microRNAs with similar nomenclature, established references and reviews do not report a well-characterized microRNA termed "miR-6766" or "MIR6766"[1][2][3]. There is insufficient evidence to consider miR-6766 a recognized, characterized molecule in the scientific literature. If this is a typographical error or confusion with another microRNA (such as miR-766), further clarification is needed. No known biological or disease roles, interacting drugs, or safety considerations have been documented for this putative entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6766 (miR-6766).